Company Filing History:
5 out of 17 
2 out of 14 
2 out of 1,572 
Years Active: 2020-2024
Title: Seokjoong Kim: Innovator in Gene Expression Regulation
Introduction
Seokjoong Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in gene expression regulation and neovascularization. With a total of seven patents to his name, Kim's work has the potential to impact various medical applications.
Latest Patents
Among his latest patents is an invention titled "Artificial genome manipulation for gene expression regulation." This invention relates to an expression control composition designed to manage the expression of duplicate genes. It also includes methods for treating or improving diseases caused by gene duplication using this composition. Another notable patent is the "Artificially-manipulated neovascularization regulatory system." This invention focuses on regulating neovascularization through an artificially manipulated factor, which can be utilized in various therapeutic contexts.
Career Highlights
Seokjoong Kim has worked with several companies, including Toolgen Inc. and Vtouch Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnology.
Collaborations
Throughout his career, Kim has collaborated with notable colleagues such as Dong Woo Song and Chunghoon Kim. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Seokjoong Kim's contributions to gene expression regulation and neovascularization highlight his role as a leading inventor in biotechnology. His patents reflect a commitment to advancing medical science and improving treatment options for various diseases.